Showing results (51-60 of 100) with videos related to
Sort By:
Pageof 10
AI Zheng = Aizheng = Chinese Journal of Cancer|January 11, 2003
[Phase II clinical trial of nedaplatin in advanced non-small cell lung cancer]Rui-hua Xu, Zhong-zhen Guan, Wen-qi Jiang, et al.The Lancet. Oncology|January 17, 2022
Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trialCaicun Zhou, Ziping Wang, Yuping Sun, et al.Cancer Immunology, Immunotherapy : CII|January 27, 2026
Efficacy and safety of anti-LAG-3 IBI110 in combination with sintilimab and chemotherapy for advanced squamous non-small cell lung cancer: a randomized phase II studyQianyi Wang, Anwen Xiong, Chenyu Mao, et al.Signal Transduction and Targeted Therapy|August 13, 2023
Envonalkib versus crizotinib for treatment-naive ALK-positive non-small cell lung cancer: a randomized, multicenter, open-label, phase III trialYunpeng Yang, Jie Min, Nong Yang, et al.JAMA Oncology|April 1, 2021
Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as First-line Treatment for Advanced Squamous Non-Small-Cell Lung Cancer: A Phase 3 Randomized Clinical TrialJie Wang, Shun Lu, Xinmin Yu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2024
Efficacy and Safety of Taletrectinib in Chinese Patients With ROS1+ Non-Small Cell Lung Cancer: The Phase II TRUST-I StudyWei Li, Anwen Xiong, Nong Yang, et al.Cancer Communications (London, England)|October 24, 2024
HLX07 alone or combined with serplulimab, cisplatin and 5-fluorouracil for advanced esophageal squamous cell carcinoma: A phase 2 studyYun Liu, Yanfeng Wang, Yanrong Zhu, et al.Journal of Inflammation Research|June 18, 2025
Prognostic Value of the SII-PNI Score in Unresectable HCC Treated with Transcatheter Arterial Chemoembolization Combined with Lenvatinib and PD-1 InhibitorsShao-Ming Wei, Zhen-Xin Zeng, Rong-Jian Pan, et al.AI Zheng = Aizheng = Chinese Journal of Cancer|December 15, 2006
[Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma]Rui-Hua Xu, Yan-Xia Shi, Zhong-Zhen Guan, et al.Eclinicalmedicine|August 18, 2023
AK112, a novel PD-1/VEGF bispecific antibody, in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC): an open-label, multicenter, phase II trialYuanyuan Zhao, Gang Chen, Jianhua Chen, et al.Pageof 10